Connect With Us:
REPORT ID 3737

United States Somatostatin Receptor Type 2 Market Report 2017

Publish Date
14-Dec-17
Pages
97
Format
Electronic (PDF)

Full report description 
In this report, the United States Somatostatin Receptor Type 2 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Somatostatin Receptor Type 2 in these regions, from 2012 to 2022 (forecast).

United States Somatostatin Receptor Type 2 market competition by top manufacturers/players, with Somatostatin Receptor Type 2 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Amryt Pharma plc
    Crinetics Pharmaceuticals Inc
    Daewoong Pharmaceutical Co Ltd
    Ipsen SA
    Progenics Pharmaceuticals Inc
    Strongbridge Biopharma plc
    Zucara Therapeutics Inc
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    CRN-00808
    Lanreotide Acetate
    PRL-2903
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hormonal Disorder
    Oncology
    Metabolic Disorder
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of contents 
Table of Contents

United States Somatostatin Receptor Type 2 Market Report 2017
1 Somatostatin Receptor Type 2 Overview
    1.1 Product Overview and Scope of Somatostatin Receptor Type 2
    1.2 Classification of Somatostatin Receptor Type 2 by Product Category
        1.2.1 United States Somatostatin Receptor Type 2 Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Somatostatin Receptor Type 2 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 CRN-00808
        1.2.4 Lanreotide Acetate
        1.2.5 PRL-2903
        1.2.6 Others
    1.3 United States Somatostatin Receptor Type 2 Market by Application/End Users
        1.3.1 United States Somatostatin Receptor Type 2 Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hormonal Disorder
        1.3.3 Oncology
        1.3.4 Metabolic Disorder
        1.3.5 Others
    1.4 United States Somatostatin Receptor Type 2 Market by Region
        1.4.1 United States Somatostatin Receptor Type 2 Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Somatostatin Receptor Type 2 Status and Prospect (2012-2022)
        1.4.3 Southwest Somatostatin Receptor Type 2 Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Somatostatin Receptor Type 2 Status and Prospect (2012-2022)
        1.4.5 New England Somatostatin Receptor Type 2 Status and Prospect (2012-2022)
        1.4.6 The South Somatostatin Receptor Type 2 Status and Prospect (2012-2022)
        1.4.7 The Midwest Somatostatin Receptor Type 2 Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Somatostatin Receptor Type 2 (2012-2022)
        1.5.1 United States Somatostatin Receptor Type 2 Sales and Growth Rate (2012-2022)
        1.5.2 United States Somatostatin Receptor Type 2 Revenue and Growth Rate (2012-2022)

2 United States Somatostatin Receptor Type 2 Market Competition by Players/Suppliers
    2.1 United States Somatostatin Receptor Type 2 Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Somatostatin Receptor Type 2 Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Somatostatin Receptor Type 2 Average Price by Players/Suppliers (2012-2017)
    2.4 United States Somatostatin Receptor Type 2 Market Competitive Situation and Trends
        2.4.1 United States Somatostatin Receptor Type 2 Market Concentration Rate
        2.4.2 United States Somatostatin Receptor Type 2 Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Somatostatin Receptor Type 2 Manufacturing Base Distribution, Sales Area, Product Type

3 United States Somatostatin Receptor Type 2 Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Somatostatin Receptor Type 2 Sales and Market Share by Region (2012-2017)
    3.2 United States Somatostatin Receptor Type 2 Revenue and Market Share by Region (2012-2017)
    3.3 United States Somatostatin Receptor Type 2 Price by Region (2012-2017)

4 United States Somatostatin Receptor Type 2 Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Somatostatin Receptor Type 2 Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Somatostatin Receptor Type 2 Revenue and Market Share by Type (2012-2017)
    4.3 United States Somatostatin Receptor Type 2 Price by Type (2012-2017)
    4.4 United States Somatostatin Receptor Type 2 Sales Growth Rate by Type (2012-2017)

5 United States Somatostatin Receptor Type 2 Sales (Volume) by Application (2012-2017)
    5.1 United States Somatostatin Receptor Type 2 Sales and Market Share by Application (2012-2017)
    5.2 United States Somatostatin Receptor Type 2 Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Somatostatin Receptor Type 2 Players/Suppliers Profiles and Sales Data
    6.1 Amryt Pharma plc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Amryt Pharma plc Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Crinetics Pharmaceuticals Inc
        6.2.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Daewoong Pharmaceutical Co Ltd
        6.3.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Ipsen SA
        6.4.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Ipsen SA Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Progenics Pharmaceuticals Inc
        6.5.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Strongbridge Biopharma plc
        6.6.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Zucara Therapeutics Inc
        6.7.2 Somatostatin Receptor Type 2 Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Somatostatin Receptor Type 2 Manufacturing Cost Analysis
    7.1 Somatostatin Receptor Type 2 Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Somatostatin Receptor Type 2

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Somatostatin Receptor Type 2 Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Somatostatin Receptor Type 2 Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Somatostatin Receptor Type 2 Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Somatostatin Receptor Type 2 Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Somatostatin Receptor Type 2 Sales Volume Forecast by Type (2017-2022)
    11.3 United States Somatostatin Receptor Type 2 Sales Volume Forecast by Application (2017-2022)
    11.4 United States Somatostatin Receptor Type 2 Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer